Identification | Back Directory | [Name]
(2S)-2β-(3-Furyl)-4aα,5,6aβ,7,10,11,11aα,11b-octahydro-11bβ-methyl-7β,10β-methano-2H-pyrano[4,3-g][3]benzoxepine-4,6,8(1H)-trione | [CAS]
66756-57-8 | [Synonyms]
Diosbulbin D 2-(furan-3-yl)-11b-methyloctahydro-2h-7,10-methanooxepino[4,5-f]isochromene-4,6,8(1h)-trione 7,10-Methano-2H-pyrano[4,3-g][3]benzoxepin-4,6,8(1H)-trione, 2-(3-furanyl)octahydro-11b-methyl-, (2S,4aS,6aS,7R,10R,11aR,11bS)- (2S)-2β-(3-Furyl)-4aα,5,6aβ,7,10,11,11aα,11b-octahydro-11bβ-methyl-7β,10β-methano-2H-pyrano[4,3-g][3]benzoxepine-4,6,8(1H)-trione | [Molecular Formula]
C19H20O6 | [MDL Number]
MFCD20274625 | [MOL File]
66756-57-8.mol | [Molecular Weight]
344.36 |
Hazard Information | Back Directory | [Uses]
Diosbulbin D has shown to induce cytotoxicity against human hepatocellular carcinoma cells, apoptosis in normal human liver L-02 cells, and constitutes of anti-inflammatory properties. | [Definition]
ChEBI: Diosbulbin D is an organic heterotricyclic compound and an organooxygen compound. | [target]
ROS |
|
Company Name: |
BioBioPha Co., Ltd.
|
Tel: |
0871-65217109 13211707573; |
Website: |
http://www.biobiopha.com |
|